A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumoursMark T. J. van Bussel, Jan H.M. Schellens, Samer El Bawab et al.|British Journal of Cancer|2020Cited by 127